Effectiveness of Echinochrome on HFD-Induced Hyperlipidemia in Rats

doi:10.1007/s13659-019-00221-4

Natural Products and Bioprospecting

2019, Vol. 9

Issue (5) : 337-344 DOI: 10.1007/s13659-019-00221-4

ORIGINAL ARTICLES

Effectiveness of Echinochrome on HFD-Induced Hyperlipidemia in Rats

Sohair R. Fahmy¹, Nashwah Ismail Zaki², Shaimaa Zakaria Eid¹, Ayman Saber Mohamed¹, Sarah S. Hassanein¹

1 Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt;
2 Physiology Department, National Organization for Drug Control and Research, Cairo, Egypt

Abstract
References
Related Articles
Metrics

Download: PDF(5252 KB) HTML ()
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract Obesity has been identified with an expanded danger of a progression of illnesses that include different organ-frameworks of the body. In the present examination, we evaluated the hypolipidemic properties of Echinochrome (Ech) pigment in a highfat diet (HFD) induced hyperlipidemia in rats. After the hyperlipidemic model was set up, rats were haphazardly separated into five groups as follows:normal control group, HFD group, Atorvastatin (ATOR) group (80 mg/kg), Ech group (1 mg/kg) and combined group ATOR + Ech. The outcomes demonstrated that Ech improves lipid profile, liver functions, kidney functions and antioxidant markers of obese rats. The findings of the present investigation indicated that the Ech possesses hypolipidemic potential in obese rats.

Keywords High-fat diet Atorvastatin Echinochrome Obesity Oxidative stress

Corresponding Authors: Ayman Saber Mohamed, Sohair R. Fahmy, Nashwah Ismail Zaki, Shaimaa Zakaria Eid, Sarah S. Hassanein E-mail: ayman81125@hotmail.com,ayman81125@cu.edu.eg;sohairfahmy@gmail.com;nashwahizaki@yahoo.com;shaimaa.zakaria14@yahoo.com;ssara@sci.cu.edu.eg

Issue Date: 30 October 2019

	Service

	E-mail this article
	E-mail Alert
	RSS
	Articles by authors

	Sohair R. Fahmy
	Nashwah Ismail Zaki
	Shaimaa Zakaria Eid
	Ayman Saber Mohamed
	Sarah S. Hassanein

Trendmd:

Cite this article:

Sohair R. Fahmy,Nashwah Ismail Zaki,Shaimaa Zakaria Eid, et al. Effectiveness of Echinochrome on HFD-Induced Hyperlipidemia in Rats[J]. Natural Products and Bioprospecting, 2019, 9(5): 337-344.

URL:

http://npb.kib.ac.cn/EN/10.1007/s13659-019-00221-4 OR http://npb.kib.ac.cn/EN/Y2019/V9/I5/337

1. W. Gao, H.W. He, Z.M. Wang, H. Zhao, X.Q. Lian, Y.S. Wang, J. Zhu, J.J. Yan, D.G. Zhang, Z.J. Yang, L.S. Wang, Lipids Health Dis. 11, 55-59 (2012)
2. S.S. Lim, T. Vos, A.D. Flaxman, Lancet 380, 2224-2260 (2010)
3. S. Saravanan, L. Pari, Eur. J. Pharmacol. 76, 279-287 (2015)
4. Y. Eguchi, H. Hyogo, M. Ono, T. Mizuta, N. Ono, K. Fujimoto, K. Chayama, T. Saibara, JSG-NAFLD J. Gastroenterol. 47, 586-595 (2012)
5. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffman, J.N. Clore, Gastroenterology 120, 1183-1192 (2001)
6. R.L. Yang, Y.H. Shi, G. Hao, W. Li, G.W. Le, J. Clin. Biochem. Nutr. 43, 154-158 (2008)
7. B.A. Golomb, M.A. Evans, Am. J. Cardiovasc. Drugs. 8, 373-418 (2008)
8. P. Kaufmann, M. Török, A. Zahno, K.M. Waldhauser, K. Brech, S. Krähenbühl, Cell Mol. Life Sci. 63, 2415-2425 (2006)
9. S. Kianbakht, F. Nabati, B. Abasi, Int. J. Mol. Cell Med. 5(3), 141-148 (2016)
10. G.M. Markus, H.K. Richard, B.B. Eduard, S.-F. Verónica, M. Katia, L. Lakshmanan, H. Hans, B. Fabio, D. Annette, CMAJ 181, E11-E18 (2009)
11. S.R. Fahmy, A.S. Mohamed, Int. J. Clin. Exp. Pathol. 8, 1649-1657 (2015)
12. A.V. Lebedev, M.V. Ivanova, D.O. Levitsky, Life Sci. 76, 863-875 (2005)
13. L.V. Boguslavskaya, N.G. Khrapova, O.B. Maksimov, Bull. Acad. Sci. USSR Div. Chem. Sci. 34, 1345-1350 (1985)
14. S.H. Jeong, H.K. Kim, I.S. Song, S.J. Noh, J. Marquez, K.S. Ko, B.D. Rhee, N. Kim, N.P. Mishchenko, S.A. Fedoreyev, V.A. Stonik, J. Han, Mar. Drugs. 12, 4602-4615 (2014)
15. A.M. Soliman, A.S. Mohamed, M.A.S. Marie, Austin J. Endocrinol Diabetes 3, 1045 (2016)
16. V. Welch-White, N. Dawkin, T. Graham, R. Pace, Lipids Health Dis. 12, 2-9 (2013)
17. A.V. Lebedev, L.V. Boguslavskaia, D.O. Levitskii, O.B. Maksimov, Biokhimiia. 53, 598-603 (1988)
18. S. Vazquez-Perez, P. Aragoncillo, N. de Las Heras, J. NavarroCid, E. Cediel, D. Sanz-Rosa, L. M. Ruilope, C. Diaz, G. Hernandez, V. Lahera and V. Cachofeiro. Nephrol. Dial Transpl. 16, 40-44 (2001).
19. M. Hattori, D.J. Nikotic-Paterson, K. Miyazaki, N.M. Isbel, H.Y. Lan, R.C. Atkin, H. Kawaguchi, K. Ito, Kidney Int. Suppl. 71, S47-S50 (1999)
20. C. Yang, C. Lium, Q. Zhoum, Y.C. Xiem, X. Qiu, X. Feng, Indian J. Pharm. Sci. 77, 103-107 (2015)
21. B.A. Bhatt, J.J. Dube, N. Dedousis, J.A. Reider, R.M. O'Doherty, Am. J. Physiol-Reg. Integ. Comp. Physiol. 290, R233-R240 (2006)
22. L. Marcoff, P.D. Thompson, J. Am. Coll. Cardiol. 49, 2231-2237 (2007)
23. F.W. Fraunfelder, A.B. Richards, Ophthalmology 115, 2282-2285 (2008)
24. P. Kapoor, A.K. Kapoor, JIACM. 14, 37-45 (2013)
25. S.A. Noeman, H.E. Hamooda, A.A. Baalash, Diabetol. Metab. Syndr. 3, 17 (2011)
26. A. Guilherme, J.V. Virbasius, V. Puri, M.P. Czech, Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008)
27. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, P.C. Butler, Diabetes 52, 102-110 (2003)
28. R. Amarowicz, J. Synowiecki, F. Shahidi, Food Chem. 51, 227-229 (1994)
29. R. Kuwahara, H. Hatatea, T. Yukia, H. Murata, R. Tanakac, Y. Hamad, L.W.T. Food Sci. Technol. 42, 1296-1300 (2009)
30. M.J. Reed, K. Meszaros, L.J. Entes, M.D. Claypoo, J.G. Pinkett, T.M. Gadbois, G.M. Reaven, Metabolism. 49, 390-1394 (2000)
31. G. Rajyalakshmi, A. Reddy, V.V. Rajesham, Int. J. Pharm. 6, 2 (2009)
32. A. Lennikov, N. Kitaichi, K. Noda, K. Mizuuchi, R. Ando, Z. Dong, J. Fukuhara, S. Kinoshita, K. Namba, S. Ohno, S. Ishida, Mol. Vis. 20, 171-177 (2014)
33. S.S. Reitman, A. Frankel, Am. J. Clin. Pathol. 28, 56-63 (1957)
34. A. Belfield, D.M. Goldberg, Arch. Dis. Child. 46, 842-486 (1971)
35. N. W. Tietz, C. A. Burtis and E. R. Ashwood. Tietz Textbook of Clinical Chemistry, pp. 122-133. Saunders, Philadelphia (1994)
36. N. W. Tietz, P. Finley and E. Pruden. Clinical Guide to Laboratory Tests Saunders, pp. 232-233. Saunders, Philadelphia (1990)
37. N. Zollner, K. Kirsch, Z. Ges. Exp. Med. 135, 545-561 (1962)
38. E.A. Stein, G. Myers, in Tietz Textbook of Clinical Chemistry, ed. by C.A. Burtis, R.E. Ashwood (WB Saunders Company, Philadelphia, 1994), pp. 1002-1993
39. W. Richmond, Clin. Chem. 19, 1350-1356 (1973)
40. H. Wieland, D. Seidel, J. Lipid Res. 24, 904-909 (1983)
41. M.F. Lopes-Virella, P. Stone, S. Ellis, J.A. Colwell, Clin. Chem. 23, 882-884 (1977)
42. J. Schirmeister, Dtsch. Med. Wschr. 89, 1940 (1964)
43. J.K. Fawcett, J.E. Soctt, J. Clin. Pathol. 13, 156-159 (1960)
44. D. Barham, P. Trinder, Analyst. 151, 142-145 (1972)
45. A. Renze, P. Margaret, JIFCC. 1, 130-139 (1989)
46. H. Ohkawa, N. Ohishi, K. Yagi, Anal. Biochem. 95, 351-358 (1979)
47. E. Beutler, O. Duron, M.B. Kelly, J. Lab. Clin. Med. 61, 882-888 (1963)
48. W.H. Habig, M.J. Pabst, W.B. Jakoby, J. Biol. Chem. 249, 7130-7139 (1974)
49. H. Aebi, Methods Enzymol. 105, 121-126 (1984)

[1]	Mohaddese Mahboubi. Caraway as Important Medicinal Plants in Management of Diseases[J]. Natural Products and Bioprospecting, 2019, 9(1): 1-12.
[2]	Kun Wei, Gang-Qiang Wang, Xue Bai, Yan-Fen Niu, He-Ping Chen, Chun-Nan Wen, Zheng-Hui Li, Ze-Jun Dong, Zhi-Li Zuo, Wen-Yong Xiong, Ji-Kai Liu. Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents[J]. Natural Products and Bioprospecting, 2015, 5(3): 129-157.
[3]	Simon CICHELLO, Pingsheng LIU, Markendya JOIS. The anti-obesity effects of EGCG in relation to oxidative stress and air-pollution in China[J]. Natural Products and Bioprospecting, 2013, 3(6): 256-266.

Viewed

Full text

Abstract

Cited

Shared

Discussed